For the Inventor, By the Inventor

Enter assignee name

Berkshire, United Kingdom

Seqirus UK Limited

USPTO Granted Patents = 37

EPO Patents = 20

Trademarks = 39

Forward Citations = 35

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Peter W Mason (11 out of 35 patents)

Philip R Dormitzer (10 out of 34 patents)

Derek T O'Hagan (8 out of 73 patents)

4. Pirada Suphaphiphat (7 out of 10 patents)

5. Nicola Groth (6 out of 7 patents)

6. Rino Rappuoli (5 out of 82 patents)

7. Giuseppe Del Giudice (5 out of 12 patents)

8. Steven Black (4 out of 4 patents)

9. Uwe Nicolay (4 out of 4 patents)

10. Heidi Trusheim (4 out of 6 patents)

11. Mario Contorni (3 out of 20 patents)

12. Ethan Settembre (3 out of 10 patents)

13. Jens-Peter Gregersen (3 out of 9 patents)

14. Raul Gomila (3 out of 3 patents)

15. Michael Franti (3 out of 8 patents)

Core Competencies:

Vaccination

Immunocompromised

Influenza Virus

mRNA Molecules

Lipid Nanoparticles

Adjuvanted Vaccines

Cell Culture

Viral Reassortment

Elderly Recipients

Squalene

Antigen Production

Needle Arrays

37 patents: Sort by Forward Citations

1. 12697382 - Vaccination of immunocompromised subjects (2026-08-04),

2. 12558412 - Vaccination of immunocompromised subjects (2026-02-24),

3. 12318442 - Preparation of influenza virus vaccine antigens (2025-06-03),

4. 12083175 - Enhancement of self-amplifying mRNA molecules within lipid nanoparticles (2024-09-10),

5. 11897918 - Compositions and methods to increase production (2024-02-13),

6. 11896660 - Reducing hospitalization in elderly influenza vaccine recipients (2024-02-13),

7. 11707520 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2023-07-25),

8. 11466257 - Cell-derived viral vaccines with low levels of residual cell DNA (2022-10-11),

9. 11406701 - Vaccination of immunocompromised subjects (2022-08-09),

10. 11249088 - Influenza potency assays (2022-02-15),

11. 11246921 - Influenza vaccines with reduced amounts of squalene (2022-02-15),

12. 11013795 - Antigenically matched influenza vaccines (2021-05-25),

13. 10946088 - Preparation of influenza virus vaccine antigens (2021-03-16),

14. 10864264 - Influenza virus reassortment (2020-12-15),

15. 10842867 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2020-11-24),

Seqirus UK Limited is a prominent player in the biopharmaceutical sector, specializing in the development and manufacture of innovative vaccines. With a strong focus on addressing public health needs, the company leverages advanced research and technology to create solutions for infectious diseases. Operating within a global framework, Seqirus is committed to enhancing vaccine accessibility and effectiveness, contributing to the overall health landscape in the UK and beyond.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

37 Patents

#6 in Berkshire

#489 in United Kingdom

#18,238 in the World

Berkshire, United Kingdom

Seqirus UK Limited

Forward Citations = 35

46 inventors:

Peter W Mason (11 out of 35 patents)

Philip R Dormitzer (10 out of 34 patents)

Derek T O'Hagan (8 out of 73 patents)

4. Pirada Suphaphiphat (7 out of 10 patents)

5. Nicola Groth (6 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…